137 related articles for article (PubMed ID: 37144290)
1. Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma.
Gulbrandsen MS; Nøding AS; Smeland KB; Eikeland SA; Kiserud CE; Hjermstad MJ; Fosså A
Leuk Lymphoma; 2023 Jun; 64(6):1139-1150. PubMed ID: 37144290
[TBL] [Abstract][Full Text] [Related]
2. Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Gerrie AS; Power MM; Shepherd JD; Savage KJ; Sehn LH; Connors JM
Ann Oncol; 2014 Nov; 25(11):2218-2223. PubMed ID: 25149708
[TBL] [Abstract][Full Text] [Related]
3. Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.
Hernæs KH; Smeland KB; Fagerli UM; Kiserud CE
BMC Cancer; 2021 Feb; 21(1):143. PubMed ID: 33557789
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver.
Lavoie JC; Connors JM; Phillips GL; Reece DE; Barnett MJ; Forrest DL; Gascoyne RD; Hogge DE; Nantel SH; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Voss NJ; Nevill TJ
Blood; 2005 Aug; 106(4):1473-8. PubMed ID: 15870180
[TBL] [Abstract][Full Text] [Related]
5. Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma.
Moskowitz AJ; Perales MA; Kewalramani T; Yahalom J; Castro-Malaspina H; Zhang Z; Vanak J; Zelenetz AD; Moskowitz CH
Br J Haematol; 2009 Jul; 146(2):158-63. PubMed ID: 19438504
[TBL] [Abstract][Full Text] [Related]
6. [High dose therapy with autologous stem cell transplantation in patients with Hodgkin's lymphoma: long-term follow-up in patients treated in one center].
Trnĕný M; Vacková B; Pytlík R; Cieslar P; Válková V; Gasová Z; Kobylka P; Trnková M; Krejcová H; Klener P
Cas Lek Cesk; 2006; 145(1):19-24. PubMed ID: 16468237
[TBL] [Abstract][Full Text] [Related]
7. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.
Kiserud CE; Fagerli UM; Smeland KB; Fluge Ø; Bersvendsen H; Kvaløy S; Holte H; Dahl AA
Acta Oncol; 2016 May; 55(5):547-53. PubMed ID: 27123741
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
9. Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life.
Smeland K; Holte H; Fagerli UM; Bersvendsen H; Hjermstad MJ; Loge JH; Murbrach K; Linnsund MD; Fluge O; Stenehjem JS; Lund MB; Kvaloy S; Kiserud CE
Haematologica; 2022 Nov; 107(11):2698-2707. PubMed ID: 35484681
[TBL] [Abstract][Full Text] [Related]
10. A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Milgrom SA; Jauhari S; Plastaras JP; Nieto Y; Dabaja BS; Pinnix CC; Smith GL; Allen PK; Lukens JN; Maity A; Oki Y; Fanale MA; Nasta SD
Cancer; 2017 Apr; 123(8):1363-1371. PubMed ID: 27984652
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes.
Engelhardt BG; Holland DW; Brandt SJ; Chinratanalab W; Goodman SA; Greer JP; Jagasia MH; Kassim AA; Morgan DS; Ruffner KL; Schuening FG; Wolff S; Bitting R; Sulur P; Stein RS
Leuk Lymphoma; 2007 Sep; 48(9):1728-35. PubMed ID: 17786708
[TBL] [Abstract][Full Text] [Related]
12. Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.
Mounier N; Anthony S; Busson R; Thieblemont C; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Morschhauser F; Feugier P; Delarue R; Ysebaert L; Sebban C; Broussais-Guillaumot F; Damaj G; Nerich V; Jais JP; Laborde L; Salles G; Henry-Amar M
Cancer; 2019 Jul; 125(13):2291-2299. PubMed ID: 30901086
[TBL] [Abstract][Full Text] [Related]
13. Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.
Keller SF; Kelly JL; Sensenig E; Andreozzi J; Oliva J; Rich L; Constine L; Becker M; Phillips G; Liesveld J; Fisher RI; Bernstein SH; Friedberg JW
Biol Blood Marrow Transplant; 2012 Apr; 18(4):640-7. PubMed ID: 21871246
[TBL] [Abstract][Full Text] [Related]
14. High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
Gopal AK; Metcalfe TL; Gooley TA; Pagel JM; Petersdorf SH; Bensinger WI; Holmberg L; Maloney DG; Press OW
Cancer; 2008 Sep; 113(6):1344-50. PubMed ID: 18623377
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
Cochrane Database Syst Rev; 2013 Jun; (6):CD009411. PubMed ID: 23784872
[TBL] [Abstract][Full Text] [Related]
16. Stem cell transplantation in Hodgkin lymphoma.
Reddy NM; Perales MA
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1097-112. PubMed ID: 25459181
[TBL] [Abstract][Full Text] [Related]
17. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.
Tarella C; Cuttica A; Vitolo U; Liberati M; Di Nicola M; Cortelazzo S; Rosato R; Rosanelli C; Di Renzo N; Musso M; Pavone E; Santini G; Pescarollo A; De Crescenzo A; Federico M; Gallamini A; Pregno P; Romano R; Coser P; Gallo E; Boccadoro M; Barbui T; Pileri A; Gianni AM; Levis A
Cancer; 2003 Jun; 97(11):2748-59. PubMed ID: 12767087
[TBL] [Abstract][Full Text] [Related]
18.
Conlon KC; Sportes C; Brechbiel MW; Fowler DH; Gress R; Miljkovic MD; Chen CC; Whatley MA; Bryant BR; Corcoran EM; Kurdziel KA; Pittaluga S; Paik CH; Lee JH; Fleisher TA; Carrasquillo JA; Waldmann TA
Cancer Biother Radiopharm; 2020 May; 35(4):249-261. PubMed ID: 32275165
[No Abstract] [Full Text] [Related]
19. Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma.
Minn AY; Riedel E; Halpern J; Johnston LJ; Horning SJ; Hoppe RT; Goodman KA
Br J Haematol; 2012 Nov; 159(3):329-39. PubMed ID: 22966754
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
